TEST:

AssureMDx

AssureMDx is a noninvasive, urine-based test which evaluates genomic changes associated with the presence of bladder cancer and can help identify high-risk patients who will benefit from clinical evaluation by a urologist. When the test is positive, hematuria patients are at increased risk for bladder cancer and should be referred to a urologist for clinical evaluation. When the test is negative, the patient is at very low risk for bladder cancer and may safely avoid invasive procedures. The AssureMDx test helps improve early detection of bladder cancer, provides greater peace of mind, and reduces the associated healthcare expenses.